# IDEX CORP (IEX) FY2026 Q3 Balance Sheet

- Company: IDEX CORP (IEX)
- Period: As of 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-28, accession number 0000832101-26-000029
- Page: https://plicit.ai/financials/iex/fy2026-q3-balance-sheet
- Chart image: https://plicit.ai/charts/iex-fy2026-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 6,878,800,000 US dollars
- **Current assets**: 1,766,500,000 US dollars
- **Non-current assets**: 5,112,300,000 US dollars
- **Liabilities**: 2,863,800,000 US dollars
- **Current liabilities**: 635,900,000 US dollars
- **Non-current liabilities**: 2,227,900,000 US dollars
- **Equity**: 4,015,000,000 US dollars
- **Noncontrolling interest**: negative 1,500,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 602,100,000 US dollars
- **Receivables – net**: 548,600,000 US dollars
- **Inventories – net**: 529,100,000 US dollars
- **Other current assets**: 86,700,000 US dollars
- **Goodwill**: 3,371,900,000 US dollars
- **Intangible assets – net**: 1,129,000,000 US dollars
- **Property, plant and equipment – net of accumulated depreciation of $702.9 and $654.3 at September 30, 2026 and December 31, 2025, respectively**: 466,900,000 US dollars
- **Other noncurrent assets**: 144,500,000 US dollars
- **Accrued expenses**: 343,400,000 US dollars
- **Trade accounts payable**: 238,300,000 US dollars
- **Dividends payable**: 53,800,000 US dollars
- **Current portion of long-term borrowings**: 400,000 US dollars
- **Long-term borrowings – net**: 1,751,100,000 US dollars
- **Deferred income taxes**: 296,100,000 US dollars
- **Other noncurrent liabilities**: 180,700,000 US dollars
- **Retained earnings**: 4,745,700,000 US dollars
- **Additional paid-in capital**: 881,700,000 US dollars
- **Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both September 30, 2026 and December 31, 2025**: 900,000 US dollars
- **Authorized: 5.0 million shares, $0.01 per share par value; Issued: None**: 0 US dollars
- **Noncontrolling interest**: negative 1,500,000 US dollars
- **Treasury stock at cost: 16.4 million shares at September 30, 2026 and 15.5 million shares at December 31, 2025**: negative 1,596,500,000 US dollars
- **Accumulated other comprehensive (loss) income**: negative 15,300,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

## Key Takeaways

- Goodwill and intangible assets total $4.50 B, 65% of everything IDEX owns.
- Take them out and shareholder equity is -$484.40 M, up from -$634.40 M at the last year-end.
- Only $400.00 K of IDEX's debt falls due within a year, so near-term repayment looks light.
- Customers prepaid $70.70 M for work IDEX has not yet delivered, a cash cushion for now.

## The Unvarnished Truth

### Strip out IDEX's acquisitions and its owners' equity turns negative

IDEX looks sturdy on the surface, yet its equity depends on the prices it paid for other companies. Goodwill and intangible assets total $4.50 B, 65% of everything the company owns, and that is more than all of its $4.02 B of shareholder equity. Strip the acquisitions out and equity sits below zero at -$484.40 M. Why would a company with $6.88 B of assets be so thin on its own tangible value? The answer starts with what it paid for.

Goodwill is where the money went. Health & Science Technologies holds 66% of that goodwill, according to the filing's goodwill table. Debt is the other side of the story: IDEX drew $260.0 M on its revolving credit line in the first nine months, and the filing says the money was used for general corporate purposes, including to finance share repurchases. Of its $602.10 M of cash, $541.90 M is held outside the United States. The filing does not say why a company holding most of its cash abroad still drew on its revolver.

For a reader, IDEX is a company built by buying other businesses and paying for them with debt. Lenders appear to have room: the covenant ratios sit far from their limits, and only $0.40 M of the debt is due within a year. Equity barely moved over the first nine months, because buybacks and dividends took the earnings that came in. What settles the question is whether the $4.50 B of acquired value still matches the prices IDEX paid. If those businesses were valued again tomorrow, would the price still hold up?

## Intelligent Insights for Investors

### How much debt does IDEX have, and how much cash sits against it?

Its cash covers only part of it: on hand, IDEX held enough for 34% of the $1.75 B it owed on September 30, 2026, with $602.10 M in the bank. The rest would have to come from cash it earns in coming quarters or from new borrowing.

### Has IDEX built up profit over its lifetime or run up a deficit?

It has built up profit: retained earnings stood at $4.75 B on September 30, 2026, up 5% from $4.50 B at the last year-end. That is profit kept in the business, net of dividends declared, though the equity behind it still rests on acquisitions.

## Intelligent Insights for Lenders

### How much room does IDEX have under its loan terms?

The covenant ratios leave wide room: the interest coverage ratio was 14.69 to 1 against a minimum of 3.0 to 1, and the leverage ratio was 1.72 to 1 against a maximum of 3.50 to 1. The company says it was in compliance with its covenants at September 30, 2026.

## Intelligent Insights for Suppliers

### Can IDEX cover the bills it must pay within a year?

On paper, yes: it had $2.78 of current assets for each dollar of bills due within a year on September 30, 2026, against $2.86 at the last year-end. How quickly those assets turn into cash decides the rest.
